subgroup analyses of meteor; randomized phase iii trial of cabozantinib vs everolimus for rcc
Published 8 years ago • 270 plays • Length 4:09Download video MP4
Download video MP3
Similar videos
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
5:42
meteor trial: cabozantinib vs everolimus in advanced renal cell carcinoma
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
2:02
dr. jorge garcia on meteor trial for rcc
-
5:49
cabozantinib improves advanced kidney cancer survival: meteor trial results
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
6:30
cabozantinib: the meteor trial
-
3:26
nivolumab and cabozantinib versus standard of care in renal cell carcinoma
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
5:55
ecc 2015: meteor trial showed cabozantinib improved survival in advanced kidney cancer
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
5:08
cabosun trial of upfront cabozantinib in metastatic rcc
-
2:12
comment: new immunotherapy options for kidney cancer
-
7:29
results from cabosun, meteor and javelin
-
4:22
cabozantinib in combination w/ nivolumab and ipilimumab of imdc intermediate or poor risk signif...
-
1:32
dr. mcgregor on the future of cabozantinib in rcc
-
1:19
phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
2:35
cabozantinib most effective treatment for metastatic papillary kidney cancer
-
3:49
cabozantinib benefit for metastatic papillary rcc demonstrated | sumanta pal